The estimated Net Worth of Jing L. Marantz is at least 622 千$ dollars as of 14 June 2024. Dr Marantz owns over 3,131 units of Krystal Biotech Inc stock worth over 622,411$ and over the last 4 years he sold KRYS stock worth over 0$.
Dr has made over 1 trades of the Krystal Biotech Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 3,131 units of KRYS stock worth 622,411$ on 14 June 2024.
The largest trade he's ever made was exercising 3,131 units of Krystal Biotech Inc stock on 14 June 2024 worth over 622,411$. On average, Dr trades about 348 units every 0 days since 2021. As of 14 June 2024 he still owns at least 3,131 units of Krystal Biotech Inc stock.
You can see the complete history of Dr Marantz stock trades at the bottom of the page.
Dr. Jing L. Marantz M.B.A., M.D., Ph.D. is the Chief Bus. Officer at Krystal Biotech Inc.
Dr D is 56, he's been the Chief Bus. Officer of Krystal Biotech Inc since . There are no older and 10 younger executives at Krystal Biotech Inc.
Over the last 7 years, insiders at Krystal Biotech Inc have traded over 166,816,526$ worth of Krystal Biotech Inc stock and bought 536,800 units worth 5,949,380$ . The most active insiders traders include Daniel Janney、Dino A Rossi、Krish S Krishnan. On average, Krystal Biotech Inc executives and independent directors trade stock every 40 days with the average trade being worth of 8,043,043$. The most recent stock trade was executed by Suma Krishnan on 11 June 2024, trading 50,000 units of KRYS stock currently worth 8,788,000$.
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
Krystal Biotech Inc executives and other stock owners filed with the SEC include: